Passa al contenuto
Merck
  • Insights in the kinetic mechanism of the eukaryotic Baeyer-Villiger monooxygenase BVMOAf1 from Aspergillus fumigatus Af293.

Insights in the kinetic mechanism of the eukaryotic Baeyer-Villiger monooxygenase BVMOAf1 from Aspergillus fumigatus Af293.

Biochimie (2014-09-18)
María Laura Mascotti, Marcela Kurina-Sanz, Maximiliano Juri Ayub, Marco W Fraaije
ABSTRACT

This work reports a detailed kinetic study of the recently discovered BVMOAf1 from Aspergillus fumigatus Af293. By performing steady state and pre-steady state kinetic analyses, it was demonstrated that the rate of catalysis is partially limited by the NADPH-mediated reduction of the flavin cofactor, a unique hallmark of BVMOAf1. In addition, the oxygenating C4a-(hydro)peroxyflavin intermediate could be spectrophotometrically detected and it was found to be the most stable among all analyzed BVMOs. To assess the possible influence of some residues on the kinetic features, model-inspired site-directed mutagenesis was performed. Among the mutants, the Q436A variant showed a slightly broader substrate scope and a better catalytic efficiency. In summary, this study describes for the first time the kinetic parameters for an eukaryotic BVMO.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Imidazolo, ReagentPlus®, 99%
Sigma-Aldrich
Imidazolo, ACS reagent, ≥99% (titration)
Sigma-Aldrich
Imidazolo, Molecular Biology, ≥99% (titration)
Sigma-Aldrich
Imidazolo, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
Imidazole buffer Solution, BioUltra, 1 M in H2O
Sigma-Aldrich
Imidazolo, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
Imidazolo, ≥99% (titration), crystalline
Sigma-Aldrich
Imidazolo, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Imidazolo, BioUltra, Molecular Biology, ≥99.5% (GC)
Supelco
Imidazolo, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Imidazolo, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Imidazolo, ReagentPlus®, 99%, Redi-Dri, free-flowing
Imidazolo, European Pharmacopoeia (EP) Reference Standard
Imidazolo, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Imidazolo, Molecular Biology, ≥99% (titration), free-flowing, Redi-Dri